Showing 241 - 260 results of 18,435 for search '(( significantly ((lower decrease) OR (we decrease)) ) OR ( significant a decrease ))', query time: 0.50s Refine Results
  1. 241
  2. 242
  3. 243
  4. 244
  5. 245
  6. 246
  7. 247

    Description of the warning label. by Yulian Ding (5984591)

    Published 2024
    “…The random parameters logit model results showed a significant overall decrease in SSB purchases when a warning label was present, indicated by a significant negative coefficient associated with the label. …”
  8. 248

    Flow chart of the study. by Yulian Ding (5984591)

    Published 2024
    “…The random parameters logit model results showed a significant overall decrease in SSB purchases when a warning label was present, indicated by a significant negative coefficient associated with the label. …”
  9. 249

    Summary statistics of the sample. by Yulian Ding (5984591)

    Published 2024
    “…The random parameters logit model results showed a significant overall decrease in SSB purchases when a warning label was present, indicated by a significant negative coefficient associated with the label. …”
  10. 250

    Product attributes and attribute levels. by Yulian Ding (5984591)

    Published 2024
    “…The random parameters logit model results showed a significant overall decrease in SSB purchases when a warning label was present, indicated by a significant negative coefficient associated with the label. …”
  11. 251

    Dataset used in this study. by Yulian Ding (5984591)

    Published 2024
    “…The random parameters logit model results showed a significant overall decrease in SSB purchases when a warning label was present, indicated by a significant negative coefficient associated with the label. …”
  12. 252

    Definitions of the variables. by Yulian Ding (5984591)

    Published 2024
    “…The random parameters logit model results showed a significant overall decrease in SSB purchases when a warning label was present, indicated by a significant negative coefficient associated with the label. …”
  13. 253

    Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx by Juan Chen (61123)

    Published 2025
    “…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…”
  14. 254
  15. 255
  16. 256
  17. 257

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  18. 258

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  19. 259

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  20. 260